Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762976
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaFudan UniversityRecruitingPhase 2
NCT07762976Recruiting
Phase 2
Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasoph...Fudan University
NCT07764107
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNational Health Research Institutes, TaiwanNot Yet RecruitingNot Applicable
NCT07764107Not Yet Recruiting
Not Applicable
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-...National Health Research...
NCT07763184
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Southern Medical UniversityNot Yet Recruiting
NCT07763184Not Yet Recruiting
—
mNGS for IFD in Patients With Hematological MalignanciesNanfang Hospital, Souther...
NCT07763431
Home-Use Dual-Light Antibacterial Photodynamic Therapy for Peri-Implant Mucositis in Full-Arch Implant ProsthesesUniversity of Medicine and Pharmacy at Ho Chi Minh CityNot Yet RecruitingNot Applicable
NCT07763431Not Yet Recruiting
Not Applicable
Home-Use Dual-Light Antibacterial Photodynamic Therapy for Peri-Implant Mucositi...University of Medicine an...
NCT07764250
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training in Elderly With Mild and Moderate Cognitive ImpairmentShifa Tameer-e-Millat UniversityRecruitingNot Applicable
NCT07764250Recruiting
Not Applicable
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training i...Shifa Tameer-e-Millat Uni...
NCT07763665
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Injury by Measurming Nucleotide-binding Oligomerization Domain-Like Receptor Pyrin Domain-containing 3 (NLRP3) Inflammasome-a Multiprotein ComplexAssiut UniversityNot Yet RecruitingPhase 4
NCT07763665Not Yet Recruiting
Phase 4
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Inju...Assiut University
NCT07762326
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple SclerosisCairo UniversityNot Yet RecruitingNot Applicable
NCT07762326Not Yet Recruiting
Not Applicable
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders an...Cairo University
NCT07764198
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult AmblyopiaJiannan HuangRecruitingNot Applicable
NCT07764198Recruiting
Not Applicable
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult Ambly...Jiannan Huang
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07763639
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors and Other Solid TumorsBaili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07763639Not Yet Recruiting
Phase 1
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck...Baili-Bio (Chengdu) Pharm...
NCT07763821
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.Assiut UniversityNot Yet Recruiting
NCT07763821Not Yet Recruiting
—
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephrit...Assiut University
NCT07762807
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS Foundation TrustRecruitingNot Applicable
NCT07762807Recruiting
Not Applicable
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS...
NCT07763444
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan UniversityCompletedNot Applicable
NCT07763444Completed
Not Applicable
The Impact of Experiential Simulation on Nursing StudentsNecmettin Erbakan Univers...
NCT07762794
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent RepairHumacyte, Inc.Not Yet RecruitingPhase 4
NCT07762794Not Yet Recruiting
Phase 4
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real Worl...Humacyte, Inc.
NCT07763886
CORRELATION BETWEEN FORWARD HEAD POSTURE, CERVICAL MUSCLES ENDURANCE, AND PROPRIOCEPTIVE FUCTIONS IN CERVICOGENIC HEADACHE AMONG LATE ADOLESCENT STUDENTS.Delta University for Science and TechnologyNot Yet Recruiting
NCT07763886Not Yet Recruiting
—
CORRELATION BETWEEN FORWARD HEAD POSTURE, CERVICAL MUSCLES ENDURANCE, AND PROPRI...Delta University for Scie...
NCT07763015
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals, Inc.Not Yet RecruitingPhase 2
NCT07763015Not Yet Recruiting
Phase 2
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals,...
NCT07762144
Clinical Cohort Construction Program of Peking University Third HospitalPeking University Third HospitalEnrolling By Invitation
NCT07762144Enrolling By Invitation
—
Clinical Cohort Construction Program of Peking University Third HospitalPeking University Third H...
NCT07762235
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive ImpairmentIstinye UniversityNot Yet RecruitingNot Applicable
NCT07762235Not Yet Recruiting
Not Applicable
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive Impairme...Istinye University
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
Result Breakdown
Not yet recruiting14 (70%)
Recruiting4 (20%)
Completed1 (5%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 13 (15%)
Phase 42 (10%)